Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Merlin anticorps (pSer518)

NF2 Reactivité: Humain WB, ELISA, IF Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN7138643
  • Antigène Voir toutes Merlin (NF2) Anticorps
    Merlin (NF2) (Neurofibromin 2 (NF2))
    Épitope
    • 27
    • 15
    • 9
    • 7
    • 6
    • 4
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    pSer518
    Reactivité
    • 76
    • 65
    • 53
    • 5
    • 4
    • 4
    • 4
    • 4
    • 4
    • 3
    • 3
    • 2
    • 1
    Humain
    Hôte
    • 87
    • 4
    • 1
    Lapin
    Clonalité
    • 89
    • 3
    Polyclonal
    Conjugué
    • 46
    • 5
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    Cet anticorp Merlin est non-conjugé
    Application
    • 70
    • 29
    • 27
    • 26
    • 19
    • 16
    • 11
    • 11
    • 6
    • 4
    • 3
    • 1
    • 1
    Western Blotting (WB), ELISA, Immunofluorescence (IF)
     Réactivité croisée
    Humain, Souris, Rat
    Purification
    Antibodies were produced by immunizing rabbits with synthetic phosphopeptide and KLH conjugates. Antibodies were purified by affinity-chromatography using epitope-specific phosphopeptide. Non-phospho specific antibodies were removed by chromatogramphy usi
    Immunogène
    Peptide sequence around phosphorylation site of serine 518 (R-L-S(p)-M-E) derived from Human Merlin.
    Isotype
    IgG
    Top Product
    Discover our top product NF2 Anticorps primaire
  • Indications d'application
    WB:1:500-1:1000, IF:1:100-1:200,
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Supplied at 1.0 mg/mL in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C,-80 °C
    Stockage commentaire
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Antigène
    Merlin (NF2) (Neurofibromin 2 (NF2))
    Autre désignation
    NF2 (NF2 Produits)
    Synonymes
    anticorps ACN, anticorps BANF, anticorps SCH, anticorps NF2, anticorps merlin, anticorps zgc:194620, anticorps zgc:194631, anticorps NF2a, anticorps nf2, anticorps neurofibromin 2, anticorps neurofibromin 2a (merlin), anticorps neurofibromin 2b (merlin), anticorps neurofibromin 2 (merlin) S homeolog, anticorps NF2, anticorps Nf2, anticorps nf2a, anticorps nf2b, anticorps nf2.S
    Sujet

    Background:

    Probable regulator of the Hippo/SWH (Sav/Wts/Hpo) signaling pathway, a signaling pathway that plays a pivotal role in tumor suppression by restricting proliferation and promoting apoptosis. Along with WWC1 can synergistically induce the phosphorylation of LATS1 and LATS2 and can probably function in the regulation of the Hippo/SWH (Sav/Wts/Hpo) signaling pathway. May act as a membrane stabilizing protein. May inhibit PI3 kinase by binding to AGAP2 and impairing its stimulating activity.

    Guang-Hui Xiao, et al. (2005) Mol. Cell. Biol , 25: 2384 - 2394.
    Hi-Su Yang, et al. (2006) Cancer Res , 66: 2708 - 2715.
    R Bohni, et al. (1994) J. Biol. Chem , 269: 14541 - 14545.
    Adam J. Ratner, et al. (2001) J. Biol. Chem , 276: 19267 - 19275.

    Aliases: ACN antibody, BANF antibody, Bilateral acoustic neuroma antibody, MERL_HUMAN antibody, Merlin antibody, Moesin ezrin radixin like protein antibody, Moesin ezrin radizin like antibody, Moesin-ezrin-radixin-like protein antibody, Neurofibromatosis 2 antibody, Neurofibromatosis type 2 antibody, Neurofibromatosis2 antibody, Neurofibromin 2 antibody, Neurofibromin-2 antibody, Neurofibromin2 antibody, NF 2 antibody, Nf2 antibody, SCH antibody, Schwannomerlin antibody, Schwannomin antibody

    UniProt
    P35240
    Pathways
    Cell-Cell Junction Organization
Vous êtes ici: